| Dr Patrick Derby, DPM | |
|
2511 W Dr Martin Luther King Jr Blvd, Tampa, FL 33607-6301 | |
| (813) 879-7850 | |
| (813) 870-3569 |
| Full Name | Dr Patrick Derby |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 5 Years |
| Location | 2511 W Dr Martin Luther King Jr Blvd, Tampa, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073075222 | NPI | - | NPPES |
| OPOAV | Other | FL | BCBS |
| 7333506 | Other | FL | CIGNA ID |
| 114530400 | Medicaid | FL | |
| 6605657 | Other | FL | AETNA |
| 15659126 | Other | CAQH ID |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Josephs Hospital | Tampa, FL | Hospital |
| Tampa General Hospital | Tampa, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| All Podiatry Group Inc. | 0042252140 | 16 |
News Archive
Australian/US biotechnology company, Novogen Limited, today announces that it has confirmed that one of its lead candidate products, TRXE-009, is showing the potential to become an important new therapy in the fight against adult and pediatric brain cancer.
Daily transcranial magnetic stimulation—an intervention that uses magnetic currents to activate certain brain areas—appears to help induce remission in patients with treatment-resistant depression, according to a report in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
We were extremely excited to launch the Impact 2020 report at our annual meeting. Our five-year strategic plan is focused on value, early-stage financing and ensuring more patient-centered discussions.
A study published by Elsevier this month in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method that facilitates the induction of a specific type of immune suppressive cells, called 'regulatory T cells' for therapeutic use.
Patients with multiple sclerosis have higher rates of depression than the general population, including people with other life-long disabling diseases. Symptoms of multiple sclerosis arise from an abnormal response of the body's immune system.
› Verified 3 days ago
| Provider Name | All Podiatry Group Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437207933 PECOS PAC ID: 0042252140 Enrollment ID: O20050531000341 |
News Archive
Australian/US biotechnology company, Novogen Limited, today announces that it has confirmed that one of its lead candidate products, TRXE-009, is showing the potential to become an important new therapy in the fight against adult and pediatric brain cancer.
Daily transcranial magnetic stimulation—an intervention that uses magnetic currents to activate certain brain areas—appears to help induce remission in patients with treatment-resistant depression, according to a report in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
We were extremely excited to launch the Impact 2020 report at our annual meeting. Our five-year strategic plan is focused on value, early-stage financing and ensuring more patient-centered discussions.
A study published by Elsevier this month in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method that facilitates the induction of a specific type of immune suppressive cells, called 'regulatory T cells' for therapeutic use.
Patients with multiple sclerosis have higher rates of depression than the general population, including people with other life-long disabling diseases. Symptoms of multiple sclerosis arise from an abnormal response of the body's immune system.
› Verified 3 days ago
| Provider Name | Tampa General Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043557853 PECOS PAC ID: 7416253828 Enrollment ID: O20160310002525 |
News Archive
Australian/US biotechnology company, Novogen Limited, today announces that it has confirmed that one of its lead candidate products, TRXE-009, is showing the potential to become an important new therapy in the fight against adult and pediatric brain cancer.
Daily transcranial magnetic stimulation—an intervention that uses magnetic currents to activate certain brain areas—appears to help induce remission in patients with treatment-resistant depression, according to a report in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
We were extremely excited to launch the Impact 2020 report at our annual meeting. Our five-year strategic plan is focused on value, early-stage financing and ensuring more patient-centered discussions.
A study published by Elsevier this month in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method that facilitates the induction of a specific type of immune suppressive cells, called 'regulatory T cells' for therapeutic use.
Patients with multiple sclerosis have higher rates of depression than the general population, including people with other life-long disabling diseases. Symptoms of multiple sclerosis arise from an abnormal response of the body's immune system.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick Derby, DPM 15815 Shaddock Dr Ste 130, Winter Garden, FL 34787-5773 Ph: (813) 400-1140 | Dr Patrick Derby, DPM 2511 W Dr Martin Luther King Jr Blvd, Tampa, FL 33607-6301 Ph: (813) 879-7850 |
News Archive
Australian/US biotechnology company, Novogen Limited, today announces that it has confirmed that one of its lead candidate products, TRXE-009, is showing the potential to become an important new therapy in the fight against adult and pediatric brain cancer.
Daily transcranial magnetic stimulation—an intervention that uses magnetic currents to activate certain brain areas—appears to help induce remission in patients with treatment-resistant depression, according to a report in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
We were extremely excited to launch the Impact 2020 report at our annual meeting. Our five-year strategic plan is focused on value, early-stage financing and ensuring more patient-centered discussions.
A study published by Elsevier this month in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method that facilitates the induction of a specific type of immune suppressive cells, called 'regulatory T cells' for therapeutic use.
Patients with multiple sclerosis have higher rates of depression than the general population, including people with other life-long disabling diseases. Symptoms of multiple sclerosis arise from an abnormal response of the body's immune system.
› Verified 3 days ago
Dr. Paul Arthur Richter, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 7926 W Hillsborough Ave, Suite G, Tampa, FL 33615 Phone: 813-886-9180 Fax: 813-888-9093 | |
Juan J Rivera, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2835 W De Leon St, Suite 101, Tampa, FL 33609 Phone: 813-254-6592 Fax: 813-254-3634 | |
Senior Foot Care Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 12903 N Howard Ave, Tampa, FL 33612 Phone: 239-297-2876 | |
Paul L Sheehy Jr Dpm Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 812 W Mlk Jr Blvd, Suite 101, Tampa, FL 33603 Phone: 813-872-8939 Fax: 813-872-8649 | |
Advanced Tampa Bay Foot Care Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4543 S Manhattan Ave, Suite 104, Tampa, FL 33611 Phone: 813-831-3813 | |
Paul L Sheehy Jr, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 812 W Mlk Jr Blvd, Suite #101, Tampa, FL 33603 Phone: 813-872-8939 Fax: 813-872-8649 | |
Dr. Saleena Ruth Niehaus, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 508 S Habana Ave Ste 230, Tampa, FL 33609 Phone: 813-877-6636 |